These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 24272997)
1. Proteomics in investigation of cancer metastasis: functional and clinical consequences and methodological challenges. Maryáš J; Faktor J; Dvořáková M; Struhárová I; Grell P; Bouchal P Proteomics; 2014 Mar; 14(4-5):426-40. PubMed ID: 24272997 [TBL] [Abstract][Full Text] [Related]
2. Biomarkers in cancer micrometastasis: where are we at? Gerges N; Jabado N Bioanalysis; 2010 May; 2(5):881-99. PubMed ID: 21083219 [TBL] [Abstract][Full Text] [Related]
3. Identification of markers associated with highly aggressive metastatic phenotypes using quantitative comparative proteomics. Terp MG; Lund RR; Jensen ON; Leth-Larsen R; Ditzel HJ Cancer Genomics Proteomics; 2012; 9(5):265-73. PubMed ID: 22990106 [TBL] [Abstract][Full Text] [Related]
4. Genomics and proteomics of bone cancer. Marguiles AG; Klimberg VS; Bhattacharrya S; Gaddy D; Suva LJ Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6217s-6221s. PubMed ID: 17062704 [TBL] [Abstract][Full Text] [Related]
5. Quantitative proteomics of primary tumors with varying metastatic capabilities using stable isotope-labeled proteins of multiple histogenic origins. Lund RR; Terp MG; Laenkholm AV; Jensen ON; Leth-Larsen R; Ditzel HJ Proteomics; 2012 Jul; 12(13):2139-48. PubMed ID: 22623409 [TBL] [Abstract][Full Text] [Related]
6. Cancer proteomics. Tan HT; Lee YH; Chung MC Mass Spectrom Rev; 2012; 31(5):583-605. PubMed ID: 22422534 [TBL] [Abstract][Full Text] [Related]
7. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery. Matta A; Ralhan R; DeSouza LV; Siu KW Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361 [TBL] [Abstract][Full Text] [Related]
13. Breast cancer classification by proteomic technologies: current state of knowledge. Lam SW; Jimenez CR; Boven E Cancer Treat Rev; 2014 Feb; 40(1):129-38. PubMed ID: 23891266 [TBL] [Abstract][Full Text] [Related]
14. Epithelial proteomics in multiple organs and tissues: similarities and variations between cells, organs, and diseases. Zhao H; Adler KB; Bai C; Tang F; Wang X J Proteome Res; 2006 Apr; 5(4):743-55. PubMed ID: 16602680 [TBL] [Abstract][Full Text] [Related]
15. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. Cheng AL; Huang WG; Chen ZC; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Peng F; Duan CJ; Xiao ZQ J Proteome Res; 2008 Jun; 7(6):2415-26. PubMed ID: 18433155 [TBL] [Abstract][Full Text] [Related]
16. Identification of key players for colorectal cancer metastasis by iTRAQ quantitative proteomics profiling of isogenic SW480 and SW620 cell lines. Ghosh D; Yu H; Tan XF; Lim TK; Zubaidah RM; Tan HT; Chung MC; Lin Q J Proteome Res; 2011 Oct; 10(10):4373-87. PubMed ID: 21854069 [TBL] [Abstract][Full Text] [Related]
17. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells. Chen YR; Juan HF; Huang HC; Huang HH; Lee YJ; Liao MY; Tseng CW; Lin LL; Chen JY; Wang MJ; Chen JH; Chen YJ J Proteome Res; 2006 Oct; 5(10):2727-42. PubMed ID: 17022644 [TBL] [Abstract][Full Text] [Related]
19. Identification of metastasis-related proteins and their clinical relevance to triple-negative human breast cancer. Sun B; Zhang S; Zhang D; Li Y; Zhao X; Luo Y; Guo Y Clin Cancer Res; 2008 Nov; 14(21):7050-9. PubMed ID: 18981002 [TBL] [Abstract][Full Text] [Related]
20. Discrepancies between primary tumor and metastasis: a literature review on clinically established biomarkers. Vignot S; Besse B; André F; Spano JP; Soria JC Crit Rev Oncol Hematol; 2012 Dec; 84(3):301-13. PubMed ID: 22710198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]